270 related articles for article (PubMed ID: 9416850)
1. Oncostatin M stimulates monocyte chemoattractant protein-1- and interleukin-1-induced matrix metalloproteinase-1 production by human synovial fibroblasts in vitro.
Langdon C; Leith J; Smith F; Richards CD
Arthritis Rheum; 1997 Dec; 40(12):2139-46. PubMed ID: 9416850
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: implications for cartilage degradation in arthritis.
Barksby HE; Milner JM; Patterson AM; Peake NJ; Hui W; Robson T; Lakey R; Middleton J; Cawston TE; Richards CD; Rowan AD
Arthritis Rheum; 2006 Oct; 54(10):3244-53. PubMed ID: 17009259
[TBL] [Abstract][Full Text] [Related]
3. The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint.
Cawston TE; Curry VA; Summers CA; Clark IM; Riley GP; Life PF; Spaull JR; Goldring MB; Koshy PJ; Rowan AD; Shingleton WD
Arthritis Rheum; 1998 Oct; 41(10):1760-71. PubMed ID: 9778217
[TBL] [Abstract][Full Text] [Related]
4. Regulation of interleukin-1beta-induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts.
Ahmed S; Pakozdi A; Koch AE
Arthritis Rheum; 2006 Aug; 54(8):2393-401. PubMed ID: 16869002
[TBL] [Abstract][Full Text] [Related]
5. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures.
Fearon U; Mullan R; Markham T; Connolly M; Sullivan S; Poole AR; FitzGerald O; Bresnihan B; Veale DJ
Arthritis Rheum; 2006 Oct; 54(10):3152-62. PubMed ID: 17009243
[TBL] [Abstract][Full Text] [Related]
6. The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis.
Okamoto H; Yamamura M; Morita Y; Harada S; Makino H; Ota Z
Arthritis Rheum; 1997 Jun; 40(6):1096-105. PubMed ID: 9182920
[TBL] [Abstract][Full Text] [Related]
7. Induction of CCL13 expression in synovial fibroblasts highlights a significant role of oncostatin M in rheumatoid arthritis.
Hintzen C; Quaiser S; Pap T; Heinrich PC; Hermanns HM
Arthritis Rheum; 2009 Jul; 60(7):1932-43. PubMed ID: 19565514
[TBL] [Abstract][Full Text] [Related]
8. The effects of 1 alpha,25-dihydroxyvitamin D(3) on matrix metalloproteinase and prostaglandin E(2) production by cells of the rheumatoid lesion.
Tetlow LC; Woolley DE
Arthritis Res; 1999; 1(1):63-70. PubMed ID: 11056661
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of chemokines by leukemia inhibitory factor, interleukin-6 and oncostatin M.
Hartner A; Goppelt-Struebe M; Hocke GM; Sterzel RB
Kidney Int; 1997 Jun; 51(6):1754-60. PubMed ID: 9186863
[TBL] [Abstract][Full Text] [Related]
10. Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo.
Langdon C; Kerr C; Hassen M; Hara T; Arsenault AL; Richards CD
Am J Pathol; 2000 Oct; 157(4):1187-96. PubMed ID: 11021823
[TBL] [Abstract][Full Text] [Related]
11. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
[TBL] [Abstract][Full Text] [Related]
12. The JAK inhibitor baricitinib inhibits oncostatin M induction of proinflammatory mediators in ex-vivo synovial derived cells.
Weston S; Macdonald JL; Williams LM; Roussou E; Kang NV; Kiriakidis S; Taylor PC
Clin Exp Rheumatol; 2022 Sep; 40(9):1620-1628. PubMed ID: 34665696
[TBL] [Abstract][Full Text] [Related]
13. An investigation of cell proliferation and soluble mediators induced by interleukin 1beta in human synovial fibroblasts: comparative response in osteoarthritis and rheumatoid arthritis.
Inoue H; Takamori M; Nagata N; Nishikawa T; Oda H; Yamamoto S; Koshihara Y
Inflamm Res; 2001 Feb; 50(2):65-72. PubMed ID: 11289656
[TBL] [Abstract][Full Text] [Related]
14. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis.
Nowell MA; Richards PJ; Fielding CA; Ognjanovic S; Topley N; Williams AS; Bryant-Greenwood G; Jones SA
Arthritis Rheum; 2006 Jul; 54(7):2084-95. PubMed ID: 16802343
[TBL] [Abstract][Full Text] [Related]
15. Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathways.
Filer A; Bik M; Parsonage GN; Fitton J; Trebilcock E; Howlett K; Cook M; Raza K; Simmons DL; Thomas AM; Salmon M; Scheel-Toellner D; Lord JM; Rabinovich GA; Buckley CD
Arthritis Rheum; 2009 Jun; 60(6):1604-14. PubMed ID: 19479862
[TBL] [Abstract][Full Text] [Related]
16. Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands.
Pierer M; Rethage J; Seibl R; Lauener R; Brentano F; Wagner U; Hantzschel H; Michel BA; Gay RE; Gay S; Kyburz D
J Immunol; 2004 Jan; 172(2):1256-65. PubMed ID: 14707104
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways.
Amin MA; Mansfield PJ; Pakozdi A; Campbell PL; Ahmed S; Martinez RJ; Koch AE
Arthritis Rheum; 2007 Jun; 56(6):1787-97. PubMed ID: 17530707
[TBL] [Abstract][Full Text] [Related]
18. The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: a time-course study using real-time quantitative reverse transcription-polymerase chain reaction.
Koshy PJ; Lundy CJ; Rowan AD; Porter S; Edwards DR; Hogan A; Clark IM; Cawston TE
Arthritis Rheum; 2002 Apr; 46(4):961-7. PubMed ID: 11953973
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous requirement of IkappaB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: implications for therapy.
Andreakos E; Smith C; Kiriakidis S; Monaco C; de Martin R; Brennan FM; Paleolog E; Feldmann M; Foxwell BM
Arthritis Rheum; 2003 Jul; 48(7):1901-12. PubMed ID: 12847684
[TBL] [Abstract][Full Text] [Related]
20. Intercellular adhesion molecule-1 mediates the inhibitory effects of hyaluronan on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts via down-regulation of NF-kappaB and p38.
Hiramitsu T; Yasuda T; Ito H; Shimizu M; Julovi SM; Kakinuma T; Akiyoshi M; Yoshida M; Nakamura T
Rheumatology (Oxford); 2006 Jul; 45(7):824-32. PubMed ID: 16449361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
